Gilead Sciences, Inc. - stock earnings

GILD Upcoming estimated earnings

DateLow RevenueAverage RevenueHigh Revenue
April 25, 2024 BeforeMarket 6.0 billion 6.4 billion 6.8 billion

GILD Quarterly earnings

DateEarningsRevenue
2023Q4 1.4 billion USD 7.1 billion USD
2023Q3 2.2 billion USD 7.1 billion USD
2023Q2 1.0 billion USD 6.6 billion USD
2023Q1 1.0 billion USD 6.4 billion USD
2022Q4 1.6 billion USD 7.4 billion USD
2022Q3 1.8 billion USD 7.0 billion USD
2022Q2 1.1 billion USD 6.3 billion USD
2022Q1 12.0 million USD 6.6 billion USD
2021Q4 382.0 million USD 7.2 billion USD
2021Q3 2.6 billion USD 7.4 billion USD
2021Q2 1.5 billion USD 6.2 billion USD
2021Q1 1.7 billion USD 6.4 billion USD
2020Q4 1.6 billion USD 7.4 billion USD
2020Q3 360.0 million USD 6.6 billion USD
2020Q2 -3.3 billion USD 5.1 billion USD
2020Q1 1.6 billion USD 5.5 billion USD
2019Q4 2.7 billion USD 5.9 billion USD
2019Q3 -1.2 billion USD 5.6 billion USD
2019Q2 1.9 billion USD 5.7 billion USD
2019Q1 2.0 billion USD 5.3 billion USD
2018Q4 3.0 million USD 5.8 billion USD
2018Q3 2.1 billion USD 5.6 billion USD
2018Q2 1.8 billion USD 5.6 billion USD
2018Q1 1.5 billion USD 5.1 billion USD
2017Q4 -3.9 billion USD 5.9 billion USD
2017Q3 2.7 billion USD 6.5 billion USD
2017Q2 3.1 billion USD 7.1 billion USD
2017Q1 2.7 billion USD 6.5 billion USD
2016Q4 3.1 billion USD 7.3 billion USD
2016Q3 3.3 billion USD 7.5 billion USD
2016Q2 3.5 billion USD 7.8 billion USD
2016Q1 3.6 billion USD 7.8 billion USD
2015Q4 4.7 billion USD 8.5 billion USD
2015Q3 4.6 billion USD 8.3 billion USD
2015Q2 4.5 billion USD 8.2 billion USD
2015Q1 4.3 billion USD 7.6 billion USD
2014Q4 3.5 billion USD 7.3 billion USD
2014Q3 2.7 billion USD 6.0 billion USD
2014Q2 3.7 billion USD 6.5 billion USD
2014Q1 2.2 billion USD 5.0 billion USD
2013Q4 791.4 million USD 3.1 billion USD
2013Q3 788.6 million USD 2.8 billion USD
2013Q2 772.6 million USD 2.8 billion USD
2013Q1 722.2 million USD 2.5 billion USD
2012Q4 762.5 million USD 2.6 billion USD
2012Q3 675.5 million USD 2.4 billion USD
2012Q2 711.6 million USD 2.4 billion USD
2012Q1 442.0 million USD 2.3 billion USD
2011Q4 665.1 million USD 2.2 billion USD
2011Q3 741.1 million USD 2.1 billion USD
2011Q2 746.2 million USD 2.1 billion USD
2011Q1 651.1 million USD 1.9 billion USD
2010Q4 629.4 million USD 2.0 billion USD
2010Q3 704.9 million USD 1.9 billion USD
2010Q2 712.1 million USD 1.9 billion USD
2010Q1 854.9 million USD 2.1 billion USD
2009Q4 802.2 million USD 2.0 billion USD
2009Q3 673.0 million USD 1.8 billion USD
2009Q2 569.1 million USD 1.6 billion USD
2009Q1 589.1 million USD 1.5 billion USD
2008Q4 568.2 million USD 1.4 billion USD
2008Q3 504.0 million USD 1.4 billion USD
2008Q2 442.8 million USD 1.3 billion USD
2008Q1 496.1 million USD 1.3 billion USD
2007Q4 401.6 million USD 1.1 billion USD
2007Q3 398.3 million USD 1.1 billion USD
2007Q2 407.9 million USD 1.0 billion USD
2007Q1 407.4 million USD 1.0 billion USD
2006Q4 -1.7 billion USD 899.2 million USD
2006Q3 -52.2 million USD 748.7 million USD
2006Q2 265.2 million USD 685.3 million USD
2006Q1 262.7 million USD 692.9 million USD
2005Q4 281.6 million USD 609.3 million USD
2005Q3 179.2 million USD 493.5 million USD
2005Q2 196.0 million USD 495.3 million USD
2005Q1 157.1 million USD 430.4 million USD
2004Q4 110.2 million USD 369.6 million USD
2004Q3 113.2 million USD 326.2 million USD
2004Q2 111.5 million USD 319.7 million USD
2004Q1 114.4 million USD 309.1 million USD
2003Q4 192.6 million USD 263.5 million USD
2003Q3 73.1 million USD 200.4 million USD
2003Q2 100.4 million USD 238.9 million USD
2003Q1 -438.1 million USD 165.1 million USD
2002Q4 35.5 million USD 145.0 million USD
2002Q3 20.8 million USD 134.0 million USD
2002Q2 19.7 million USD 109.4 million USD
2002Q1 -3.9 million USD 78.4 million USD
2001Q4 131.6 million USD 74.3 million USD
2001Q3 -25.2 million USD 50.9 million USD
2001Q2 -32.4 million USD 50.7 million USD
2001Q1 -21.7 million USD 57.8 million USD
2000Q4 -29.3 million USD 55.3 million USD
2000Q3 -17.6 million USD 45.1 million USD
2000Q2 -4.2 million USD 50.0 million USD
2000Q1 -5.8 million USD 45.2 million USD
1999Q4 -9.0 million USD 48.8 million USD
1999Q3 -30.4 million USD 38.4 million USD
1999Q2 -15.0 million USD 8.7 million USD
1999Q1 -15.8 million USD 4.9 million USD
1998Q4 -16.3 million USD 9.0 million USD
1998Q3 -17.6 million USD 3.0 million USD
1998Q2 -14.8 million USD 7.0 million USD
1998Q1 -7.4 million USD 13.6 million USD
1997Q4 -12.4 million USD 9.9 million USD
1997Q3 -10.3 million USD 4.9 million USD
1997Q2 2.7 million USD 19.7 million USD
1997Q1 -7.9 million USD 5.5 million USD
1996Q4 -8.0 million USD 5.8 million USD
1996Q3 9.3 million USD 24.7 million USD
1996Q2 -12.2 million USD 2.2 million USD
1996Q1 -10.8 million USD 800000 USD
1995Q3 -8.4 million USD 1.1 million USD
1995Q2 -7.9 million USD 900000 USD
1995Q1 -8.9 million USD 900000 USD
1994Q4 -8.2 million USD 1.3 million USD
1994Q3 -7.0 million USD 1.6 million USD
1994Q2 -7.2 million USD 1.1 million USD
1994Q1 -8.4 million USD 1.1 million USD
1993Q4 -6.7 million USD 1.1 million USD
1993Q3 -5.8 million USD 1.0 million USD
1993Q2 -4.8 million USD 1.0 million USD
1993Q1 -5.7 million USD 1.0 million USD
1992Q4 -3.9 million USD 1.0 million USD
1992Q3 -2.7 million USD 1.0 million USD
1992Q2 -1.8 million USD 1.1 million USD
1992Q1 ? USD 1.9 million USD
1991Q4 ? USD 500000 USD
1991Q3 ? USD 200000 USD
1991Q2 ? USD 200000 USD
1991Q1 -1.0 million USD 1.2 million USD
1990Q4 -900000 USD 100000 USD
1990Q3 -1.0 million USD 100000 USD
1990Q2 -1.0 million USD 100000 USD

GILD Yearly earnings

DateEarningsRevenue
2023 5.7 billion USD 27.1 billion USD
2022 4.6 billion USD 27.3 billion USD
2021 6.2 billion USD 27.3 billion USD
2020 89.0 million USD 24.7 billion USD
2019 5.4 billion USD 22.4 billion USD
2018 5.5 billion USD 22.1 billion USD
2017 4.6 billion USD 26.1 billion USD
2016 13.5 billion USD 30.4 billion USD
2015 18.1 billion USD 32.6 billion USD
2014 12.1 billion USD 24.9 billion USD
2013 3.1 billion USD 11.2 billion USD
2012 2.6 billion USD 9.7 billion USD
2011 2.8 billion USD 8.4 billion USD
2010 2.9 billion USD 7.9 billion USD
2009 2.6 billion USD 7.0 billion USD
2008 2.0 billion USD 5.3 billion USD
2007 1.6 billion USD 4.2 billion USD
2006 -1.2 billion USD 3.0 billion USD
2005 813.9 million USD 2.0 billion USD
2004 449.4 million USD 1.3 billion USD
2003 -72.0 million USD 867.9 million USD
2002 72.1 million USD 466.8 million USD
2001 52.3 million USD 233.8 million USD
2000 -56.8 million USD 195.6 million USD
1999 -66.5 million USD 169.0 million USD
1998 -56.1 million USD 32.6 million USD
1997 -28.0 million USD 40.0 million USD
1996 -21.7 million USD 33.4 million USD
1995 -27.4 million USD 2.7 million USD
1994 -31.3 million USD 4.9 million USD
1993 -25.7 million USD 4.1 million USD
1992 -14.1 million USD 4.2 million USD
1991 -4.5 million USD 2.8 million USD
1990 -4.0 million USD 1.3 million USD

GILD

List: Challengers

Price: 73.44USD

52 week price:
70.65
87.87

Dividend Yield: 4.22%

5-year range yield:
3.30%
5.05%

Forward Dividend Yield: 4.22%

Payout Ratio: 65.12%

Payout Ratio Range:
-1137.70%
2915.81%

Dividend Per Share: 3.08 USD

Earnings Per Share: 4.73 USD

P/E Ratio: 15.59

Exchange: NMS

Sector: Healthcare

Industry: Drug Manufacturers - General

Volume: 2.7 million

Ebitda: 2.4 billion

Market Capitalization: 91.2 billion

Average Dividend Frequency: 4

Years Paying Dividends: 10

DGR3: 3.21%

DGR5: 5.30%

Links: